-
Predictors of neonatal outcome in early-onset placental dysfunction.
Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, Germer U, Moyano D, Turan S, Hartung J, Bhide A, Muller T, Bower S, Nicolaides KH, Thilaganathan B, Gembruch U, Ferrazzi E, Hecher K, Galan HL, Harman CR.
Obstet Gynecol 2007;109:253-61. -
Maternal left ventricular diastolic and systolic long-axis function during normal pregnancy.
Bamfo JE, Kametas NA, Nicolaides KH, Chambers JB.
Eur J Echocardiogr 2007;8:360-368. -
Maternal cardiac function in fetal growth-restricted and non-growth-restricted small-for-gestational age pregnancies.
Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH.
Ultrasound Obstet Gynecol 2007;29:51-57. -
Reference ranges for tissue Doppler measures of maternal systolic and diastolic left ventricular function.
Bamfo JE, Kametas NA, Nicolaides KH, Chambers JB.
Ultrasound Obstet Gynecol 2007;29:414-20. -
Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial.
Alfirevic Z, Allen-Coward H, Molina F, Vinuesa CP, Nicolaides K.
Ultrasound Obstet Gynecol 2007;29:47-50. -
Placental ABCA1 expression is reduced in primary antiphospholipid syndrome compared to pre-eclampsia and controls.
Albrecht C, Soumian S, Tetlow N, Patel P, Sullivan MH, Lakasing L, Nicolaides K, Williamson C.
Placenta 2007;28:701-8. -
Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses.
von Kaisenberg CS, Brand-Saberi B, Jonat W, Nicolaides KH.
Der Gynäkologe 1999;32:193-199. -
Lymphatic vessel hypoplasia in fetuses with Turner syndrome.
von Kaisenberg CS, Nicolaides KH, Brand-Saberi B.
Hum Reprod 1999;14:823-6. -
Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta -hCG and PAPP-A at 10-14 weeks of gestation.
Tul N, Spencer K, Noble P, Chan C, Nicolaides K.
Prenat Diagn 1999;19:1035-42. -
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:231-7. -
Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery.
Souka AP, Heath V, Flint S, Sevastopoulou I, Nicolaides KH.
Obstet Gynecol 1999;94:450-4. -
Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH.
Am J Med Genet 1999;86:205-7. -
Maternal age and gestation-specific risk for trisomy 21.
Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:167-70. -
Nuchal translucency as a marker of congenital heart disease.
Perdu M, Hyett JA, Sharland G, Snijders RS, Nicolaides KH.
Contracept Fertil Sex 1999;27:I-V. -
Some psychometric properties of the Texas Grief Inventory adjusted for miscarriage.
Nikcevic AV, Snijders R, Nicolaides KH, Kupek E.
Br J Med Psychol 1999;72:171-8. -
Investigation of the cause of miscarriage and its influence on women's psychological distress.
Nikcevic AV, Tunkel SA, Kuczmierczyk AR, Nicolaides KH.
BJOG 1999;106:808-13. -
Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks.
Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;14:307-10. -
Assessment of umbilical arterial and venous flow using color Doppler.
Lees C, Albaiges G, Deane C, Parra M, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;14:250-5. -
Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH.
BMJ 1999;318:81-5. -
The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by Doppler ultrasound.
Fowler D, Albaiges G, Lees C, Jones J, Nicolaides K, Miell J.
Hum Reprod 1999;14:2881-5.